NEWS BRIEF
Computed tomography (CT) todayThis year marks a significant milestone for GE HealthCare: 50 years of innovation in CT. The journey began in 1974 with the launch of the world’s first whole-body CT scanner—a breakthrough that transformed disease diagnosis and treatment. Since then, GE HealthCare has consistently advanced CT technology, introducing solutions that enhance image quality, reduce scan times, and lower radiation doses. Today’s CT systems leverage AI and machine learning for intelligent efficiency, delivering faster, more precise readings to help radiologists detect subtle abnormalities with greater confidence.
However, healthcare continues to face significant challenges. CT departments are under increasing strain from rising patient volumes, driven by aging populations and chronic diseases. This surge in demand, coupled with staffing shortages and high stress, leads to burnout, turnover, and impacts on productivity and care quality.
As RSNA attendees look to the future, GE HealthCare honors its legacy by staying at the forefront of innovation, committed to meeting the evolving needs of CT departments and advancing clinical excellence.
Revolution Apex platform
GE HealthCare continues advancing its Revolutionᵀᴹ Apex platform capabilities with series of new features to help improve image quality, workflow, and clinical capabilities – especially in cardiology.
The platform’s 160mm detector configuration, Revolution Apex Elite, can not only achieve 1-beat, high definition, motion free coronary images at any heart rate, but now extends this unique capability to its recently FDA cleared ECG-less Cardiac solution, which can acquire cardiac images without the aid of the patients’ ECG signal/trace. This technology is applied in examinations where it is clinically advantageous to prioritize patient access or speed when the ECG signal is unavailable. Beyond its 160 mm detector, Revolution Apex platform offers its 0.23 second rotation time to its 80 mm configuration as well to further enhance its cardiac capability.
At #RSNA24, the company is also excited to introduce TrueFidelity DL images for cardiac. Exclusively available on Revolution Apex platform, this new feature harnesses the power of deep learning to enable outstanding detail at low doses, with improved visual sharpness for confident reporting and accepted image texture.
The system also boasts a new Energy Saving Mode 2.0, which transitions the scanner into low power mode during extended periods of non-operation to help reduce power consumption by approximately 80% in unit kW and can achieve over a 30% reduction1 in daily energy consumption (in kWh).
Revolution Ascend platform
Revolutionᵀᴹ Ascend platform exclusively boasts True Enhance DL – recently FDA cleared – which uses a dedicated Deep Neural Network (DNN) to estimate monochromatic, 50 kev like GSI images from single-energy X-ray to increase contrast resolution for challenging oncology cases and other exams. The AI-based solution provides clinicians a simple workflow and incredible image quality.
Now, this solution can be paired with TrueFidelity DL to help clinicians achieve images that have less noise, enhanced sharpness, and better noise texture than images obtained with the previous generation True Enhance DL. Additionally, clinicians using Revolution Ascend platform can enjoy high resolution TrueFidelity DL kernels for lung and bone imaging, a faster image reconstruction speed as well as overlapped reconstruction features to enhance resolution on multiplanar images.
“Implementing True Enhance DL combined with TrueFidelity DL has transformed our imaging process,” shares Dr. Naoki Ito, Chief Radiologist, Toda Central Hospital, Japan.2 “The standout improvement has been the remarkable noise texture uniformity, especially in challenging areas like the liver parenchyma. This uniformity ensures that subtle differences in tissue densities are more accurately captured, reducing misinterpretation of diseased versus healthy tissue.”
Smart Subscription
Both True Enhance DL and TrueFidelity DL also are now available to new and existing Smart Subscription users – enabling healthcare systems’ to quickly and easily adoption the impressive AI-based technologies across their entire fleet.
Smart Subscription is a subscription-based service that helps keep healthcare systems computing platform and software up to date and keep pace with clinical and workflow innovations. It provides a broad range of application packages across many different services, providing radiology teams with consistent access to solutions they require, across all systems and sites. Packages focus on reconstruction and image quality, general imaging, cardiology and neurology.
Revolution Maxima
Extending the value of its AI-powered solutions, GE HealthCare is proud to extend the capabilities of TrueFidelity DL to Revolutionᵀᴹ Maxima customers. Compared to current iterative reconstruction technology, TrueFidelity DL can elevate every image to a powerful first impression with impressive image quality performance,3 and preferred image sharpness and noise texture,4 without compromising dose performance. As a result, the technology can improve reading confidence across a wide range of clinical applications such as head, whole body and cardiovascular, for patients of all ages.
AW Trajectory Planning available with Imactis CT-Navigation
Providing highly detailed images of internal structures – such as bones, organs, and tumors – CT-guided intervention can assist clinicians in performing minimally invasive procedures that guide stereotactic needles through the anatomy to biopsy or deliver treatment directly to affected tissue.
New this year, GE HealthCare is expanding the capabilities of its CT-Navigationᵀᴹ solution – which offers detailed, real-time, 3D CT images for stereotactic needle guidance – to now plan multiple needles and interpret procedure planning images sent from the company’s AW Trajectory Planning software. These new capabilities afford interventionalists the opportunity to choose their optimal workflow while gaining greater visibility and confidence in needle placement, while patients benefit from more accurate and precise care.
AI-powered CT applications
At #RSNA24, GE HealthCare is also proud to introduce several new AI-powered applications designed to help drive greater efficiency with streamlined workflows:
- • CardIQ Suite: An integrated workflow for the seamless review of calcium scoring and CCTA data. The suite features a fully automated calcium scoring algorithm that quickly identifies calcium burden and location, providing both total and per territory scores within seconds, and includes the ability to visualize and estimate the volume of heart fat.5 Additionally, readers can immediately proceed to the CCTA read using advanced 2D and automated 3D processing tools as well as enjoy automated coronary segmentation and tracking AI algorithms to significantly reduce the need for manual intervention, enhancing efficiency with ready-to-read multi-planar images.
- • VersaViewerᵀᴹ:6 A modernized and simplified multimodality visualization solution designed to optimize the presentation of AI results, reducing clicks and time needed to review data in the most frequent radiology workflows, especially when no advanced application is required. This intuitive viewer enables radiologists and clinicians to seamlessly process, review, and analyze 2D, 3D, and 4D images – helping ensure accuracy, repeatability, and efficiency in medical image reading workflows.
MEDIA CONTACT
Margaret Steinhafel Global Communications Director Molecular Imaging & Computed Tomography margaret.steinhafel@gehealthcare.com M: +1 608 381 8829
1Energy saving 2.0 according to the COCIR SRI 2015 for CT, which simulate 24 hours of daily use with 20 patients scans and 12 hours in low power mode.
2The views and opinions expressed are those of the speakers and do not necessarily reflect the official policy or position of GE HealthCare.
3Image quality comparisons between DLIR and ASiR-V, were evaluated by phantom tests of MTF, SSP, axial NPS, standard deviation of image noise, CT Number accuracy, CNR, and artefact analysis. Additionally, LCD was demonstrated in phantom testing using a model observer with the head and body MITA CT IQ Phantoms (CT191, CT189 The Phantom Laboratory). DLIR and ASiR‐V reconstructions were performed using the same raw data.
4As demonstrated in a clinical evaluation consisting of 60 cases and 9 physicians, where each case was reconstructed with both DLIR and ASiR‐V and evaluated by 3 of the physicians. In 100% of the reads, DLIR’s image sharpness was rated the same as or better than ASiR‐V’s. In 91% of the reads, DLIR’s noise texture was rated better than ASiR‐V’s. This rating was based on each individual reader’s preference.
5CardIQ Suite is 510(k) pending at the US FDA. It is not CE marked. Not available for sale in the U.S. or EU countries.
6VersaViewer is 510(k) pending at the US FDA. It is not CE marked. Not available for sale in the U.S. or EU countries.
2The views and opinions expressed are those of the speakers and do not necessarily reflect the official policy or position of GE HealthCare.
3Image quality comparisons between DLIR and ASiR-V, were evaluated by phantom tests of MTF, SSP, axial NPS, standard deviation of image noise, CT Number accuracy, CNR, and artefact analysis. Additionally, LCD was demonstrated in phantom testing using a model observer with the head and body MITA CT IQ Phantoms (CT191, CT189 The Phantom Laboratory). DLIR and ASiR‐V reconstructions were performed using the same raw data.
4As demonstrated in a clinical evaluation consisting of 60 cases and 9 physicians, where each case was reconstructed with both DLIR and ASiR‐V and evaluated by 3 of the physicians. In 100% of the reads, DLIR’s image sharpness was rated the same as or better than ASiR‐V’s. In 91% of the reads, DLIR’s noise texture was rated better than ASiR‐V’s. This rating was based on each individual reader’s preference.
5CardIQ Suite is 510(k) pending at the US FDA. It is not CE marked. Not available for sale in the U.S. or EU countries.
6VersaViewer is 510(k) pending at the US FDA. It is not CE marked. Not available for sale in the U.S. or EU countries.